Contemporary Drug Therapy for Renal Cell Carcinoma—Evidence Accumulation and Histological Implications in Treatment Strategy

Renal cell carcinoma (RCC) is a heterogeneous disease comprising a variety of histological subtypes. Approximately 70–80% of RCC cases are clear cell carcinoma (ccRCC), while the remaining subtypes constitute non-clear cell carcinoma (nccRCC). The medical treatment of RCC has greatly changed in rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamana, Kazutoshi, Ohashi, Riuko, Tomita, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687261/
https://www.ncbi.nlm.nih.gov/pubmed/36359359
http://dx.doi.org/10.3390/biomedicines10112840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687261/
https://www.ncbi.nlm.nih.gov/pubmed/36359359
http://dx.doi.org/10.3390/biomedicines10112840

Ejemplares similares